Labcorp director granted 773 restricted stock units

Labcorp Holdings Inc. director Victor Bulto Carulla was granted 773 Restricted Stock Units (RSUs) on February 10, 2026, as reported in a Form 4 insider filing.

Rhea-AI Filing Summary

Labcorp Holdings Inc. director Victor Bulto Carulla was granted 773 Restricted Stock Units (RSUs) on February 10, 2026, as reported in a Form 4 insider filing. Each RSU represents the contingent right to receive one share of Labcorp common stock.

The RSUs vest fully on February 10, 2027, meaning the director must remain eligible through that date to receive the underlying shares. Following this grant, the director beneficially owns 909 RSUs in total, all held in a direct ownership capacity.

Insider Trade Summary

Grant/Award: 773 shares

Grant/Award 1 txn

Insider Bulto Carulla Victor

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	773	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 909 contracts (Direct)

Footnotes (3)

1. F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. F2. The Restricted Stock Units vest fully on February 10, 2027.
3. F3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Labcorp (LH) report for Victor Bulto Carulla?

Labcorp reported that director Victor Bulto Carulla received a grant of 773 Restricted Stock Units on February 10, 2026. These RSUs are a form of equity compensation and each unit represents the right to receive one share of Labcorp common stock.

How many restricted stock units were granted to the Labcorp (LH) director?

The Labcorp director was granted 773 Restricted Stock Units on February 10, 2026. This award increases his total RSU holdings to 909 units, all reported as directly owned, according to the Form 4 insider transaction disclosure.

When do the newly granted Labcorp (LH) restricted stock units vest?

The newly granted Labcorp restricted stock units vest fully on February 10, 2027. Vesting means the director will become entitled to receive Labcorp common shares underlying the RSUs if the vesting conditions are satisfied through that date.

What does each Labcorp (LH) restricted stock unit represent in this Form 4?

Each restricted stock unit in this Form 4 represents the contingent right to receive one share of Labcorp Holdings Inc. common stock. The units convert into actual shares only after the vesting date and other applicable conditions are met.

How many Labcorp (LH) restricted stock units does the director own after this grant?

After this grant, the director beneficially owns 909 Restricted Stock Units in total. This figure reflects the aggregate number of RSUs held directly, as reported in the Form 4 insider ownership table and accompanying footnotes.

Was the Labcorp (LH) RSU grant a purchase or a compensation award?

The RSU grant to the Labcorp director is reported as a grant, award, or other acquisition under transaction code "A." The transaction price is shown as $0 per unit, indicating it is compensation rather than an open-market stock purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 11:00 AM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bulto Carulla Victor

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/10/2026		A		773		(2)	(2)	Common Stock	773	$0	909(3)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. The Restricted Stock Units vest fully on February 10, 2027.

3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Victor Bulto Carulla	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.